Serological Assays for the Detection and Characterization of Influenza Viruses

Back to opportunities

RFP10

Serological Assays for the Detection and Characterization of Influenza Virusesview on SAM.gov

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › CDC OFFICE OF ACQUISITION SERVICES

Posted Dec 11, 2025

Due Feb 15, 2026

Atlanta, GA

NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing

Sol # 75D30125R73235

AI Summary

• Amendment 5 issues for the original solicitation seeks to re-establish communication with Jennifer Gartzke at Amtrak.
• No eligibility or set-aside criteria are provided in this amendment notice; procurement remains an unrestricted full and open competition.
• Further details of the solicitation are contained within the attached SF30.
• No specific scope, technical requirements, geographic constraints, or deadlines are included in Amendment 5.

Description

Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.

Classification

NAICS325413

PSC CodeQ301

Place of Performance

CityAtlanta

StateGA

CountryUNITED STATES

Contracting Office

OfficeCDC OFFICE OF ACQUISITION SERVICES

CityATLANTA

StateGA

ZIP30333

Contacts

Jennifer Gartzke

jgartzke@cdc.gov

Attachments (10)